EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction

Name: EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction
Published: 2022
License: Public Domain

Zhijun Sun · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

gut-microbiota heart-failure short-chain-fatty-acids

heart failure, heart failure with preserved ejection fraction, gut microbiota, sglt2 inhibitor, myocardial fibrosis, short-chain fatty acids, derived metabolite, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction

Related documents